TFA
IART icon

Transamerica Financial Advisors’s Integra LifeSciences IART Stock Holding History

Transamerica Financial Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188 Buy
+20
New +$220 ﹤0.01% 1645
2025
Q4 		– Sell
-65
Closed -$931 – 1868
2025
Q3 		$931 Buy
+65
New +$890 ﹤0.01% 1181
2013
Q3 		– Sell
-612
Closed -$10K – 611
2013
Q2 		$10K Buy
+612
New +$8.97K ﹤0.01% 424

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Transamerica Financial Advisors's IART Position: Q1 2026 in Review

Transamerica Financial Advisors opened a new position in Integra LifeSciences (IART) in Q1 2026: 20 shares worth $188. The stake represents ﹤0.01% of the portfolio and ranks #1645 among its holdings. This is a return to the name: Transamerica Financial Advisors previously reported a position in IART as recently as Q3 2025.

Transamerica Financial Advisors first reported a position in IART in Q2 2013 and has held it in 3 quarters since. The position peaked at $10K in Q2 2013. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Transamerica Financial Advisors held 20 shares of Integra LifeSciences worth $188 as of Q1 2026.
  • Integra LifeSciences was a new Transamerica Financial Advisors position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1645 holding.
  • Transamerica Financial Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 3 quarters since.
  • Transamerica Financial Advisors's Integra LifeSciences position peaked at $10K in Q2 2013.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.